Status:
NOT_YET_RECRUITING
In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Vulvar Squamous Cell Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
This study aims to investigate the expression of FAP by phosphor imaging in invasive vulvar squamous cell carcinoma specimens. This in vitro study will include all consecutive tumour specimens stored ...
Detailed Description
Vulvar cancer is a rare gynaecological tumour, affecting 2.5 out of 100,000 women per year. The most common histological type is squamous cell carcinomas. Current guidelines suggest 2-\[18F\]fluoro-2-...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed diagnosis of invasive vulvar cancer with squamous cell histotype, both from primary tumour site and excised metastatic LNs.
- Availability of both FFPE and OCT stored samples from each primary tumour site and (when available) from the corresponding metastatic groin lymph nodes.
- Samples stored in sufficient quantity not to be completely exhausted by their use for this study.
- Optimal stored sample
- Available clinical and histopathological data
Exclusion
- \- Coexistence of primary tumours other than vulvar cancer
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06911801
Start Date
April 1 2025
End Date
November 1 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, RM, Italy, 00168